MBX Biosciences, Inc. Common Stock
MBX Biosciences, Inc. Common Stock (MBX) Net Income & Profit History
Annual & trailing net income, net margin, YoY change, and peer profitability context.
MBX · net income · updated Jun 8, 2026
Core profitability metrics
MBX · net income · margin · TTM · CAGRNet income was −$87.0M for FY2025 (fiscal year ending 2025-12-31), down 40.5% year-over-year. Net profit margin was —.
Annual net income history
▸ FMP /income-statement · Annual · MBX net income history · MBX profit margin
Annual net income data
Net income vs peers (Healthcare)
About Net Income & Methodology
MBX Biosciences, Inc. Common Stock (MBX) reported net income of −$87.0M for FY2025 (fiscal year ending 2025-12-31), down 40.5% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.
MBX Biosciences, Inc. Common Stock has not yet achieved annual profitability based on available data (4 fiscal years). The company has reported net losses across all available periods.
MBX Biosciences, Inc. Common Stock's net profit margin was — for FY2025, based on the latest annual results.
Investors sometimes search for "MBX Biosciences, Inc. Common Stock net worth" — the company's market capitalization is a separate figure from MBX net income. Data sourced from FMP /income-statement · US GAAP · USD.
Frequently asked questions
MBX net income · 4 questionsMBX Biosciences, Inc. Common Stock is not currently profitable on an annual basis. The company reported a net loss of $87.0M for FY2025.
▸ Source: FMP /income-statement · GAAP · MBX Biosciences, Inc. Common Stock · MBX Biosciences, Inc. Common Stock SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026